Correlation Between Virpax Pharmaceuticals and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Kalvista Pharmaceuticals.
Diversification Opportunities for Virpax Pharmaceuticals and Kalvista Pharmaceuticals
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virpax and Kalvista is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Kalvista Pharmaceuticals. In addition to that, Virpax Pharmaceuticals is 2.21 times more volatile than Kalvista Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about 0.05 per unit of volatility. If you would invest 809.00 in Kalvista Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of 21.00 from holding Kalvista Pharmaceuticals or generate 2.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Kalvista Pharmaceuticals |
Virpax Pharmaceuticals and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Kalvista Pharmaceuticals
The main advantage of trading using opposite Virpax Pharmaceuticals and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |